Diagnosis of type 1 vs. 2A and 2M von Willebrand disease.
作者： E. J. FAVALORO
DOI: 10.1111/J.1365-2516.2011.02628.X
关键词: Von Willebrand disease 、 Medicine 、 Internal medicine 、 Text mining 、 Gastroenterology
摘要:
sci-hub.se 参考文章(10)
Ioana C Nitu-Whalley, Anne Riddell, Christine A Lee, K John Pasi, Dale Owens, M Said Enayat, Stephen J Perkins, P Vincent Jenkins, None, Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling. Thrombosis and Haemostasis. ,vol. 84, pp. 998- 1004 ,(2000) , 10.1055/S-0037-1614162
T. DUTT, S. BURNS, N. MACKETT, C. BENFIELD, R. LWIN, R. KEENAN, Application of UKHCDO 2004 guidelines in type 1 von Willebrand Disease - a single centre paediatric experience of the implications of altered or removed diagnosis Haemophilia. ,vol. 17, pp. 522- 526 ,(2011) , 10.1111/J.1365-2516.2010.02452.X
Emmanuel Favaloro, Roslyn Bonar, Geoff Kershaw, John Sioufi, Ross Baker, Mark Hertzberg, Alison Street, Katherine Marsden, Reducing Errors in Identification of von Willebrand Disease: The Experience of the Royal College of Pathologists of Australasia Quality Assurance Program Seminars in Thrombosis and Hemostasis. ,vol. 32, pp. 505- 513 ,(2006) , 10.1055/S-2006-947865
E. J. FAVALORO, Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM‐1VWD): a rebuttal Journal of Thrombosis and Haemostasis. ,vol. 6, pp. 1999- 2001 ,(2008) , 10.1111/J.1538-7836.2008.03090.X
M. Laffan, S. A. Brown, P. W. Collins, A. M. Cumming, F. G. H. Hill, D. Keeling, I. R. Peake, K. J. Pasi, The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organization. Haemophilia. ,vol. 10, pp. 199- 217 ,(2004) , 10.1111/J.1365-2516.2004.00894.X
Anne F. Riddell, P. Vincent Jenkins, Ioana C. Nitu-Whalley, Angus H. McCraw, Christine A. Lee, Simon A. Brown, Use of the collagen‐binding assay for von Willebrand factor in the analysis of type 2M von Willebrand disease: a comparison with the ristocetin cofactor assay British Journal of Haematology. ,vol. 116, pp. 187- 192 ,(2002) , 10.1046/J.1365-2141.2002.03199.X
Wayne L. Chandler, Ellinor I.B. Peerschke, Donna D. Castellone, Piet Meijer, Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience. American Journal of Clinical Pathology. ,vol. 135, pp. 862- 869 ,(2011) , 10.1309/AJCPH5JK4ONENPAE
Emmanuel Favaloro, Toward a new paradigm for the identification and functional characterization of von Willebrand disease. Seminars in Thrombosis and Hemostasis. ,vol. 35, pp. 060- 075 ,(2009) , 10.1055/S-0029-1214149
Emmanuel J. Favaloro, Detection of von Willebrand Disorder and Identification of Qualitative von Willebrand Factor Defects American Journal of Clinical Pathology. ,vol. 114, pp. 608- 618 ,(2000) , 10.1309/2PMF-3HK9-V8TT-VFUN
Emmanuel Favaloro, Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder. Seminars in Thrombosis and Hemostasis. ,vol. 37, pp. 440- 455 ,(2011) , 10.1055/S-0031-1281028